[1]
M. . van de Sande, “Pexidartinib improves physical functioning and stiffness in patients with tenosynovial giant cell tumor: results from the ENLIVEN randomized clinical trial”, ActaO, vol. 92, no. 4, pp. 493–499, May 2021.